Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


Advances in Cell Based Assays

11 Nov 2014 - 12 Nov 2014 - London, UK



Bookmark and Share


SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.

We have worked closely with an array of industry KOLs and scientific leaders to host a packed conference agenda for the 7th annual conference this autumn

Expand your scientific horizons as we ask the questions: 

  • How have recent advances in high throughput sample expression techniques opened up new possibilities for primary HTS within the biologics industry? 
  • What are the current challenges of bioassay method development and how can we validate these with reference to cell based assays and regulatory guidelines in drug development? 
  • What is the next generation of target identification and screening technologies? 
  • How easy is it to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm?
  • How can we exploit gene editing in human cell lines to provide novel, isogenic assays? 
  • How are new technologies impacting the industry? 
  • 3D cell culture, how can this be used in oncology research? 
  • What is the next generation of cell based assays?

Key Speakers Include:

  • Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology & Science, GSK
  • Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca R&D
  • Dr Lesley Jenkinson, Scientist 1, Medimmune
  • Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
  • Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
  • Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
  • Dr Marianne Uteng, PhD, Head of Cellular Models & HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
  • Anker Jon Hansen, Principal Scientist, Novo Nordisk
  • Daniel Nolan, Director of Research, Angiocrine Bioscience

For further details and to download a copy of the PDF,  visit http://www.smi-online.co.uk/goto/2014cellbasedassay36.asp 

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!